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Abstract
Bone marrow (BM) clots are routinely sampled in aspiration tests, and their sections 
are prepared for histological observation by hematoxylin and eosin (H&E) staining. 
However, H&E-stained sections are considered less informative than those stained by 
the May-Grünwald Giemsa (M-G) stain; thus, diagnosis using H&E-stained clot samples 
is challenging for pathologists. In fact, the diagnostic evaluation is limited to the obser-
vation of cellular morphology and the myeloid-erythroid cell ratio. Pathologists leave 
cellular observation to laboratory hematologists, who generally use M-G staining. In 
this chapter, the utility of bone marrow clot specimens for diagnosis by H&E staining is 
reviewed. Specifically, the review provides a descriptive and illustrative explanation of 
the diagnosis of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and 
myelodysplastic syndrome/myelocytic proliferative neoplasm (MDS/MPN) and dem-
onstrates the possibility of diagnosis on the basis of the characteristic features of blast 
cells. Clot specimens appear to be useful for the diagnosis of hematopoietic dysplasia by 
pathologists, and this approach can provide more informative findings for hematologists.
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1. Introduction
Bone marrow (BM) clots and their specimens can be evaluated histopathologically by hema-
toxylin and eosin (H&E) staining [1, 2]. However, this method is considered to yield limited 
information regarding cellular morphology, myeloid-erythroid cell ratio, size and morphol-
ogy of megakaryocytes [3], increase in multiple myeloma [4], involvement of lymphoma, and 
metastatic tumor such as neuroblastoma [5–7]. In particular, BM clot sections comprising 
sinusoidal blood are inadequate for morphological interpretation [2]. However, the cellblock 
technique ensures the capture of cells required for diagnosis, and laboratories routinely apply 
this sample preparation technique for enhancing the usability of the BM clot specimen [2, 8]. 
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To assist in morphologic diagnosis, immunohistochemistry (IHC) is available for assess-
ment and immunophenotyping. For instance, by IHC, the marker glycophorin can assess the 
myeloid-erythroid cell ratio, and spectrin can efficiently detect erythroid cellular lineage [9]. 
P53 can also be used for differential diagnosis between refractory anemia and aplastic anemia 
[10]. An international Working Party for the Standardization of Bone Marrow IHC was formed 
by the International Council for Standardization in Hematology to prepare a set of guide-
lines for the standardization of handling BM specimens and reports [11]. While the histological 
examination of BM introduces new aspects of blood disease, the diagnosis of hematopoietic 
disorders using H&E-stained BM clot sections remains a challenge for nonhematopathologists. 
In fact, hematopoietic disorders have been diagnosed using May-Grünwald Giemsa (M-G) 
staining by hematologists and pathologists, and the findings obtained from H&E-stained BM 
clot sections are used as a reference for those obtained from M-G–stained samples.
This review discusses the information obtained from H&E-stained BM clot sections and its 
advantages and limitations over M-G–stained BM clot sections. The techniques are discussed 
with respect to examination of erythrocytes and myelocytes and the diagnosis of acute myeloid 
leukemia (AML), myelodysplastic syndrome (MDS), and myelodysplastic syndrome/myelo-
cytic proliferative neoplasm (MDS/MPN).
2. Overview of various blast cells
2.1. Erythroblasts
In H&E-stained samples, it is difficult to distinguish between erythroblasts, myeloblasts, and 
megakaryoblasts. Erythroblasts have a large nucleus that occupies the whole cell. In H&E-
stained sections, the nucleus is observed to be pale, basophilic, and homogenous, with a 
fine appearance. Myeloblast lineages have more eosinophilic and rough cytoplasm than the 
erythroblasts, with distinct nucleoli (Figure 1A and B). Megakaryoblasts have transparent, 
lobulated nucleoli, with a higher nuclear-cytoplasmic ratio than that in megakaryocytes. The 
cytoplasmic border is frequently observed, and cell membranous projections are occasionally 
observed in some of the megakaryoblasts (Figure 1C).
2.2. Immature myelocytic lineage
In general, the morphological characteristics of myelocytic developmental stages have not 
been sufficiently described using H&E-stained clot samples. This is probably because of the 
difficulty in recognizing the cytoplasmic granules in the H&E-stained sections. However, 
H&E-stained sections provide incomplete morphological information regarding the devel-
opmental stages. In comparison with erythroblasts, myelocytic lineages are larger and have 
eosinophilic cytoplasm. Pro-myelocytes are smaller than myeloblasts and have a halo sur-
rounding the nucleus, which is sometimes observed in M-G–stained samples (Figure 2A). 
Myelocytes and meta-myelocytes are easily identifiable owing to their segmented nuclei and 
smaller size than that of myelocytes (Figure 2B and C). Eosinophilic and basophilic lineages 
are identifiable because of the presence of distinct granules (Figure 2D).
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Figure 1. Morphology of erythroblasts and myeloblasts. (A) an erythroblast showing a transparent nucleus with 
condensed nucleoli (600×). (B) a myeloblast showing a transparent nucleus with one prominent eosinophilic nucleolus. 
The cytoplasm is eosinophilic, rough, and heterogeneously condensed (600×). (C) Two megakaryoblasts show transparent 
and lobulated nuclei with prominent eosinophilic nucleoli. The cytoplasm is eosinophilic, rough, and heterogeneously 
condensed. The edges are irregular, with a number of villi (600×).
Figure 2. Morphology of myelocyte lineages detected by H&E staining. Immature neutrophil lineages (A–C) and 
immature eosinophil lineages (D). (A) A pro-myelocyte showing a nucleus surrounded by halo (represented by an 
arrow). Nucleoli are not prominent relative to myeloblasts. The cytoplasm is eosinophilic, rough, and heterogeneously 
condensed (600×). (B) A myelocyte showing a regular oval nucleus with a contour and without indentation. The 
cytoplasm is eosinophilic, rough, and heterogeneously condensed (600×). (C) A meta-myelocyte showing a U-shaped or 
bent nucleus. The cytoplasm is eosinophilic, rough, and heterogeneously condensed. No nucleoli are visible (600×). (D) 
Variable immature eosinophil lineages. The arrow indicates a pro-myelocyte, and the arrowhead indicates a myelocyte. 
A mature eosinophil can be seen in the upper-left corner (600×).
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Figure 3. Erythroid lineages detected by H&E staining. (A) Two basophilic erythroblasts represent large nuclei 
(represented by arrows). Nucleoli are not prominent relative to pro-erythroblasts. The cytoplasm is basophilic, rough, 
and heterogeneously condensed (600×). (B) Three metachromatic erythroblasts represent lacy and oval nuclei (indicated 
by two arrowheads). The cytoplasm is baso-eosinophilic, rough, and heterogeneously condensed. Two orthochromatic 
erythroblasts represent condensed and oval nuclei (indicated by two arrowheads). The cytoplasm is eosinophilic and 
rough (600×).
3. H&E-stained AML
3.1. Identifying erythrocytic lineages and AML by H&E-stained BM clots
To determine the utility of H&E-stained BM clots for the diagnosis of megaloblastic leukemia, 
megaloblastoid cells in MDS, or erythroleukemia, the H&E staining properties of erythrocytic 
lineages were considered. Pro-erythroblasts are identifiable by their basophilic cytoplasm, 
transparent nucleus, and multiple deformed nucleoli. A basophilic erythroblast is smaller 
and has a relatively large nucleus, bearing thick or coarse chromatin (Figure 3A). The nucleus 
occupies a relatively small part of the cell compared to that in basophilic erythroblasts. 
Importantly, owing to two highly contrasting colors in H&E staining, two distinct types of 
erythroblasts can be observed: polychromatic and orthochromatic. The polychromatic eryth-
roblast has a lacy nucleus and baso-eosinophilic cytoplasm, while the orthochromatic eryth-
roblast has eosinophilic cytoplasm, in which the nucleus is small, pyknotic, homogeneous, 
and structure-less, and ultimately becoming blue-black (Figure 3B).
3.2. Identifying myeloblasts and AML by H&E-stained BM clots
In this study, the utility of H&E-stained BM clots in diagnosing classic AML subtypes was 
also examined. H&E-stained clots were prepared for M2, M3, M4, M5, M6, and M7 accord-
ing to the classic French-American-British classification. Cases of M2, acute leukemia with 
maturation, as specified in WHO 2008 classification, were the most frequent AML cases 
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encountered; in these cases, myeloblastic leukemic cells were observed. They have similar 
cytological features as those of normal myeloblasts: (i) eosinophilic, rough cytoplasm and 
(ii) a prominent nucleolus. Figure 4A shows leukemic marrow consisting of myeloblastic 
leukemic cells. M4, acute myelomonocytic leukemia (Figure 4C), and M5, acute monocytic 
leukemia (Figure 4D), have common features of monoblastic cells and are relatively easily 
identifiable due to a U-shaped nucleus with prominent dual nucleoli. Chromatin condensa-
tion was observed in the immature phenotype of monocytic leukemic cells in M4 and M5. 
The latter is a mix of monoblasts and monocytes and has pyknotic and condensed chromatin. 
In M6, acute erythroleukemia, atypical erythroblast-like leukemic cells were observed. The 
rough margin of the nucleus and basophil is a feature of these leukemic cells. In M7, acute 
megakaryocytic leukemia, the cells are transparent and lobulated without a distinct nucleus, 
which is observed in MDS. Furthermore, abnormal, deformed, and intensely stained nuclei 
are observed in MDS/MPN.
Figure 4. AML diagnosis using H&E staining. (A) Two M2 leukemic cells (AML with maturation) of various sizes mimic 
myeloblastic morphology and show irregular transparent nuclei with prominent eosinophilic nucleoli (600×). (B) Two M3 
leukemic cells mimic pro-myelocytic morphology but present irregular transparent nuclei with prominent eosinophilic 
nucleoli (600×). (C) Two M4 acute myelomonocytic leukemic (AMMoL) cells, mimicking monocytic and myeloblastic 
morphology but presenting irregular transparent nuclei with prominent eosinophilic nucleoli (600×). (D) M5 acute 
monocytic leukemic cells are a mixture of two types of cells: Monoblasts and pro-monocytes. They mimic monoblastic 
morphology but present an irregular transparent nucleus with prominent eosinophilic nucleoli. Monoblasts have roughly 
circular and delicate lacy chromatin nuclei with one or two prominent nucleoli. Pro-monocytes have more convoluted 
nuclei, and the nucleoli are not prominent (600×). (E) M6 leukemic cells mimic erythroblastoid morphology but present 
irregular transparent nuclei with prominent eosinophilic nucleoli (600×). (F) M7 leukemic cells mimic myeloblastic 
morphology but present irregular transparent multilobed nuclei with prominent eosinophilic nucleoli (600×).
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Figure 6. Dysplastic erythrocytes observed by H&E staining. (A, B) nuclear-cytoplasmic dissociation. Arrows represent 
the dysplastic erythroblasts that have baso-eosinophilic cytoplasm. (C, D) abnormal pro-erythroblasts. Arrows represent 
the abnormally hyperlobated nuclei.
Figure 5. Dysplastic megakaryocytes detected by H&E staining. Megakaryocytes have round, dispersed nuclei (A, B, C). 
Two or three dispersed nuclei are observed (600×).
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3.3. Dysplastic megakaryocytes in refractory anemia with excess blasts and MDS/MPN
In H&E-stained clot specimens of refractory anemia with excess blasts and MDS, abnormal 
megakaryocytes, which include micromegakaryocytes and megakaryocytes with large mono-
nuclear form, and dispersed round nucleoli were observed.
Morphological changes and increase in the number of megakaryocytes are informative for 
diagnosis. Micromononuclear megakaryocytes are detected in MDS, while large, over-mature 
megakaryocytes have been observed to increase in number in myeloproliferative neoplasms 
[12]. In anaplastic anemia, the megakaryocytes decrease definitively in number without any 
evident morphological abnormality [13]. By two-color contrast, megakaryocytic morphologi-
cal abnormality is more distinct than that by M-G staining. Nuclear-cytoplasmic dissociation 
was more identifiable in H&E-stained specimens. As shown in Figure 5, polynucleated cells 
and cells with lobulated nuclei were identified in pro-erythroblasts of BM clot samples of 
MDS patients (Figure 5A–C).
Figure 7. Dysplastic myelocytes observed by H&E staining. (A–D) dysplastic metamyelocytes maturing into neutrophils, 
which have blots in the cytoplasm (indicated by arrows).
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In the erythroblast lineage, nuclear-cytoplasmic dissociation (Figure 6A and B) [2], evident as 
hemoglobin production in the cytoplasm without enucleation, is identifiable in H&E-stained 
specimens because of distinct two-color contrast.
Multinuclear abnormal pro-erythroblasts are also the hallmark of dysplasia (Figure 6C and D) 
[2]. Furthermore, basophilic heterogeneity in the cytoplasm is observed. Neutrophils exhib-
ited a “blot” or localized heterogeneous staining in the cytoplasm, which is frequently seen 
in H&E-stained specimens (Figure 7A–C) [2]. In addition, a ring-shaped nucleus, which is 
observed in murine neutrophils, was observed in MDS and MDS/MPN (Figure 7D) [2].
4. H&E and M-G staining
Most pathologists are more familiar with H&E-stained samples than with M-G–stained sam-
ples in routine diagnostic work. As demonstrated in this study, H&E-stained specimens of 
BM, as well as M-G–stained samples, were available despite the difficulty in observation of 
granules in the cytoplasm in the myelocytic lineage. In this chapter, high-power magnifica-
tion images are provided for understanding features of individual hematopoietic lineages for 
further clarifying morphological features of the subjects.
As demonstrated, H&E specimens allow the identification of myeloblasts. Therefore, the 
identification of “blasts” in H&E-stained sections should be clearly defined. In contrast to 
the M-G-stained sections, H&E-stained sections do show basophilic cytoplasm; rather, the 
transparency of the nucleus with one or more nucleoli is more identifiable as the feature 
of blasts in H&E staining. This phenomenon represents another feature of dysplasia with 
deformity in the shape with or without atypical morphological findings of the nucleus. In 
dysplasia, hyperlobulated or ring nuclei were observed, which is a diagnostic feature of dys-
myelopoiesis. In addition, basophilic heterogeneity, exudation, or a “blot” in the erythroblast 
cytoplasm is identified in dysplasia. This basophilic exudation was clearer in H&E-stained 
specimens than in M-G-stained sections. In addition, H&E-stained clot samples are suffi-
ciently useful for the observation of morphological changes and for the assessment of mega-
karyocytic features.
H&E-stained clot specimens are advantageous for diagnosing AML subtypes because they 
allow better identification of hematopoietic dysplastic cells than M-G–stained sections 
do. Pathologists can integrate findings from the three staining methods: H&E, M-G, and 
IHC: for the decisive diagnosis of AML subtypes. Routine histological observations using 
M-G or H&E staining will be more useful in combination with flow cytometry analysis for 
immunohistological assessment using anti-CD33 and anti-CD13, a set of antibodies used 
to accurately diagnose AML. Myelodysplasia is also identifiable by H&E staining. Using 
high magnification, such as 1000×, the blot and localized heterogeneous staining or bud-
ding of the nucleus is identifiable by H&E staining. In fact, this high-power magnification 
provides more cytological and histological findings for facilitating the diagnosis of MDS 
and MDS/MPN.
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5. Discussion
5.1. Terminology: dysplastic, atypical, and blastic findings and interrelationship with 
hematological neoplasm
Dysplastic, atypical and abnormal, and blastic findings, together with hypercellularity, com-
pose the core concepts of hematological neoplastic entities in BM pathology. It is possible to 
understand the interrelationship of the entities by organizing concepts on the basis of their 
morphological findings (Figure 8). Dysplasia refers to specified morphological features that 
are distinct from other abnormal or atypical morphologies. As an important example, dys-
plastic megakaryocytes have circular, dispersed nuclei, which differ from atypical and irreg-
ular megakaryocytes in MPN and MDS/MPN. Thus, the terms “abnormal” and “atypical” 
should be used to describe the morphological changes other than morphological changes in 
MDS. The cytological spectrum of atypical lymphocytes is extremely broad. For example, 
small- to large-sized cells with often regular or indented nuclei, moderately condensed chro-
matin, moderate-to-faint basophilic cytoplasm without azurophilic granules and sometimes 
with microvacuoles are atypical findings [14].
On the other hand, the term “blast” refers to “immature” cells, which have a transparent 
nucleus with a prominent clear nucleus. For example, the “centroblast” is a morphologi-
cal concept that refers to lymphocytes that have a specified morphological feature, such as 
prominent nucleoli representing an immunologically activated state. As another example, 
“B-lymphoblasts” refer to the activated B-lymphocytes that undergo hypersomatic mutations 
and the class switch of immunoglobulin genes. In other words, blastic lymphocytes corre-
spond to the lymphocytes with gene recombination. Myeloblasts and erythroblasts, however, 
do not necessarily correspond to specific genetic alterations but correspond to the activated 
state of the first stage of differentiation. Distinguishing these morphological features from 
hyperplastic marrow will elucidate the mutual relationships among AML, AML arising from 
MDS, MDS, MDS/MPN, and MPN. MDS, AML, and MPN are specific entities on the basis of 
dysplastic, blastic (>20% of nucleated cell in BM), and hypercellular findings, respectively. 
Figure 8. Interrelationships of hematopoietic neoplasms. Dysplastic, blastic findings, together with hypercellularity, 
compose the core concepts of hematological neoplastic entities.
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AML arising from MDS and MDS/MPN are the hybrid entities of dysplasia and blastic find-
ings and dysplastic and hypercellular findings, respectively. On the basis of these three 
morphological findings, the interrelationships among hematopoietic neoplasms can well be 
understood (Figure 8).
6. Conclusion
Diagnostic evaluation should include H&E-based assessment of morphological dysplastic 
findings. H&E-stained BM clot specimens have advantage in diagnosis of hematopoietic neo-
plasms, because they better allow identification of hematopoietic dysplastic and abnormal 
cells than M-G-stained sections by cases. Pathologists can integrate findings from the two 
staining methods, H&E, and M-G for decisive diagnosis of hematopoietic neoplasms.
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